BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation
Llambi, Fabien, Wang, Yue-Ming, Victor, Bernadette, Yang, Mao, Schneider, Desiree M., Gingras, Sébastien, Parsons, Melissa J., Zheng, Janet H., Brown, Scott A., Pelletier, Stéphane, Moldoveanu, Tudor, Chen, Taosheng, Green, Douglas R.
Published in Cell (07.04.2016)
Published in Cell (07.04.2016)
Get full text
Journal Article
Discoveries and controversies in BCL‐2 protein‐mediated apoptosis
Zheng, Janet H., Viacava Follis, Ariele, Kriwacki, Richard W., Moldoveanu, Tudor
Published in The FEBS journal (01.07.2016)
Published in The FEBS journal (01.07.2016)
Get full text
Journal Article
Preclinical development of SGN-CD47M: Protease-activated antibody technology enables selective tumor targeting of the innate immune checkpoint receptor CD47
Levengood, Matthew R, Carosino, Christopher M, Zhang, Xinqun, Lucas, Sasha, Ortiz, David J, Westendorf, Lori, Chin, Alice P, Martin, Arlan D, Wong, Abbie, Hengel, Shawna M, Sun, Hao, Zeng, Weiping, Yumul, Roma, Dominguez, Melissa Mc, Chen, Yufei, Zheng, Janet H, Karlsson, Courtney A B, Trang, Vivian H, Senter, Peter D, Gardai, Shyra J
Published in Molecular cancer therapeutics (28.10.2024)
Published in Molecular cancer therapeutics (28.10.2024)
Get full text
Journal Article